© 2003 Archives of Disease in Childhood Fetal and Neonatal Edition
LETTER
Amiodarone and breast feeding
1 Pharmacy Department, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK; catherine.hall@trvi.nuth.northy.nhs.uk
2 Neonatal Unit, Royal Victoria Infirmary
Keywords: amiodarone; breast feeding; supraventricular tachycardia
| The first 150 words of the full text of this article appear below. |
An infant was born at 33+2 weeks gestation by caesarean section after an in utero diagnosis of fetal ascites and tachycardia. The mother had received treatment during pregnancy with flecainide, amiodarone, and propranolol. The amiodarone was prescribed initially at 200 mg three times a day and was reduced to twice a day after 11 days.
The mother was keen to breast feed the baby. In previous reports of amiodarone and breast feeding, amiodarone treatment was for a maternal indication and hence continued post partum.1,2 In this case, the amiodarone treatment stopped at delivery. However, because of the long terminal half life of amiodarone (about 50 days3), it could take several months for the level to fall. As one of the adverse effects of amiodarone is thyroid toxicity, the babys thyroid function was assessed and found to be normal. A decision was made to allow the mother to breast feed,
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



